ANRO

Alto Neuroscience Inc. (ANRO)

NYSE: ANROUSD
20.50 USD
-0.18 (-0.89%)
AT CLOSE (11:59 AM EDT)
20.52
+0.02 (+0.07%)
POST MARKET (AS OF 08:10 PM EDT)
🔴Market: CLOSED
Open?$20.70
High?$21.42
Low?$19.85
Prev. Close?$20.50
Volume?201.8K
Avg. Volume?266.2K
VWAP?$20.51
Rel. Volume?0.76x
Bid / Ask
Bid?$20.15 × 100
Ask?$22.60 × 200
Spread?$2.45
Midpoint?$21.38
Valuation & Ratios
Market Cap?654.9M
Shares Out?31.9M
Float?22.4M
Float %?72.0%
P/E Ratio?N/A
P/B Ratio?4.33
EPS?-$1.98
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?15.69Strong
Quick Ratio?15.69Strong
Cash Ratio?15.58Strong
Debt/Equity?0.13Low
ValuationATTRACTIVELY VALUED
Score
83/100
P/E?
N/A
P/B?
4.33FAIR
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
-7.6CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
-41.8%WEAK
ROA?
-34.2%WEAK
Cash Flow & Enterprise
FCF?$-51793000
Enterprise Value?$497.4M
Related Companies
Loading...
News
Profile
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
Employees
68
Market Cap
654.9M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2024-02-02
Address
650 CASTRO STREET, SUITE 450
MOUNTAIN VIEW, CA 94041
Phone: 773-255-5012